Nu-Med Plus (NUMD) Change in Account Payables (2012 - 2025)
Nu-Med Plus (NUMD) reported Change in Account Payables of $356.0 for Q4 2025, down 98.46% on a YoY basis from $23190.0 in Q4 2024, and up 104.84% sequentially from -$7357.0 in Q3 2025.
Nu-Med Plus (NUMD) Change in Account Payables (2012 - 2025) Analysis & Trends
Nu-Med Plus (NUMD) has 14 years of Change in Account Payables data on file, last reported at $356.0 in Q4 2025.
- For the quarter ending Q4 2025, Change in Account Payables fell 98.46% year-over-year to $356.0; the trailing twelve-month figure through Dec 2025 stood at $5163.0 (down 85.23% YoY), and the FY2025 full-year result was $5163.0, down 85.23% from the prior year.
- Change in Account Payables climbed to $356.0 in Q4 2025, from -$7357.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $35200.0 in Q4 2021 to a low of -$44175.0 in Q4 2022.
- A 5-year average of $2807.7 and a median of $1028.0 in 2023 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables slumped 4082.51% in 2023 and soared 1441.89% in 2024, its largest moves.
- Tracing NUMD's Change in Account Payables over 5 years: stood at $35200.0 in 2021, then tumbled by 225.5% to -$44175.0 in 2022, then surged by 103.4% to $1504.0 in 2023, then soared by 1441.89% to $23190.0 in 2024, then slumped by 98.46% to $356.0 in 2025.
- Business Quant data shows NUMD's Change in Account Payables at $356.0 in Q4 2025, -$7357.0 in Q3 2025, and $12209.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - | 356.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 356.00 |
| Dec 31, 2025 | 356.00 |
| Sep 30, 2025 | -7,357.00 |
| Sep 30, 2025 | -7,357.00 |
| Jun 30, 2025 | 12,209.00 |
| Jun 30, 2025 | 12,209.00 |
| Mar 31, 2025 | -45.00 |
| Mar 31, 2025 | -45.00 |
| Dec 31, 2024 | 23,190.00 |
| Dec 31, 2024 | 23,190.00 |
| Sep 30, 2024 | 9,583.00 |
| Sep 30, 2024 | 9,583.00 |
| Jun 30, 2024 | -6,190.00 |
| Jun 30, 2024 | -6,190.00 |
| Mar 31, 2024 | 8,368.00 |
| Mar 31, 2024 | 8,368.00 |
| Dec 31, 2023 | 1,504.00 |
| Dec 31, 2023 | 1,504.00 |
| Sep 30, 2023 | -7,654.00 |
| Sep 30, 2023 | -7,654.00 |